Clinical importance of cytogenetics in acute myeloid leukaemia.
about
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemiaPediatric AML: From Biology to Clinical ManagementThe prognostic and functional role of microRNAs in acute myeloid leukemiaClinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewGenomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype.A novel insertion ins(18;5)(q21.1;q31.2q35.1) in acute myeloid leukemia associated with microdeletions at 5q31.2, 5q35.1q35.2 and 18q12.3q21.1 detected by oligobased array comparative genomic hybridizationPrognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemiaEarly Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case StudyPossible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemiaTargeting cell cycle regulators in hematologic malignancies.Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Multicolor karyotyping in acute myeloid leukemia.Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.Acute promyelocytic leukemia with unusual karyotype.Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaExamination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland.Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experienceDetection of NPM1 exon 12 mutations and FLT3 - internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia.A de novo acute myeloid leukemia (AML-M4) case with a complex karyotype and yet unreported breakpoints.A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.Review: genetic models of acute myeloid leukaemia.Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date.Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.Next-generation sequencing identifies a novel ELAVL1-TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208.Diagnostic utility of multiprobe fluorescence in situ hybridization assay for detecting cytogenetic aberrations in acute leukemia.Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia.Cytogenetic harvesting of commonly used tumor cell lines.Prognostic value of brain and acute leukemia cytoplasmic gene expression in egyptian children with acute myeloid leukemia.Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours.Frequency of 11q23/MLL gene rearrangement in Egyptian childhood acute myeloblastic leukemia: Biologic and clinical significance.11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia: report from an international workshop.
P2860
Q24291902-DCDF3795-272D-435F-A0F6-DEB6C8BD9709Q26799773-CBDDB12A-C136-4A84-A0CD-FC6BC65C0DD9Q27693865-4C85B80C-03E1-45DC-830A-EA43B490E834Q28301344-5B4CBEA9-B545-4BB9-8AB7-86908F12A291Q33939071-E376A561-8E8D-4679-BE94-6DCB1C70DB98Q34268171-5FD16E42-4AB7-4570-9BC9-815DB6406E83Q34316768-EE630FC6-BA82-4120-B420-B96A662392C1Q34480479-D947EB1E-CDCD-4EEB-9054-EA9DB725FC56Q35062514-3BB0978F-6C2F-4BB0-9711-80E08DE587CDQ35334436-CB86C6EA-7781-4BBB-9022-673746B6C79AQ35615901-F9C21EA2-74E2-41C8-8162-ECBEC4BEB6D8Q35635534-F6626007-C9F9-4FE5-A4AC-D2E6BEC123AFQ35651744-C8F4F314-967A-4565-87CF-3F15F94A24F9Q35749329-71C4C205-3DAD-45FE-9837-B442813B7243Q35849784-5FF6171C-BCA5-41E5-B1C9-821CE06F2BABQ35887901-795FF762-80C3-4D02-9316-E7361462C58DQ36129030-78EFB1C7-2680-4118-90CD-91A5073EF84AQ36228256-2584A0B6-1185-478B-BC0E-CCDF1ED19C12Q36512601-08333847-1EA9-48F6-8938-FCA153D03F7AQ36582324-23E201AD-71B8-4D2E-81C3-978F6D094948Q36713551-892C9262-C221-43DD-9587-24CFB2B911D9Q36840125-8331804F-247D-4764-A3DC-B9AC504FFA3CQ36858928-2982AAF6-6677-4CA2-98FB-9E2733BE5C41Q37041909-0932744D-CF36-41BA-9946-F511B7C9A5EEQ37080843-E246D702-80CF-4BC6-AD39-FCAAF86E6026Q37372832-7BA881C3-C4C8-4947-88DA-E1616B1B0876Q37418318-14515825-6DBF-4AD0-BDF8-3B8F4AB01AC2Q38270780-BEB2FF6D-0CEC-455C-8538-CA553DBD95EBQ38489443-6EEC433F-C269-4D4F-ADAD-F41D5C959377Q38770271-069FD566-047D-492A-B6C6-B81FC7412759Q38960276-F950E60D-095F-47F2-992D-A9E0502A8AADQ39025570-B0092BE5-3BE6-4C5E-AC2C-233E6A45EA29Q40150005-012E3918-4829-4A4A-8B2E-91E4E07616E4Q40219910-054FED19-0724-4347-BD60-47A5786F7F3DQ40631821-D30867FF-1FB2-426E-B753-455A1ECC1B8CQ41607636-751C9054-FACB-4100-ADE9-52C894E72F01Q41787764-29F1C69A-8B5A-42BA-9766-6EF4C32CFFC2Q43012375-EE2B6FF9-1407-4D0A-90AC-3444122DD26DQ43938705-C65A81C2-5B58-46AD-B0E7-60F12C050A89Q44003370-7486D115-FBB3-4D65-8F9E-655C7F4CCCF1
P2860
Clinical importance of cytogenetics in acute myeloid leukaemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical importance of cytogenetics in acute myeloid leukaemia.
@ast
Clinical importance of cytogenetics in acute myeloid leukaemia.
@en
Clinical importance of cytogenetics in acute myeloid leukaemia.
@nl
type
label
Clinical importance of cytogenetics in acute myeloid leukaemia.
@ast
Clinical importance of cytogenetics in acute myeloid leukaemia.
@en
Clinical importance of cytogenetics in acute myeloid leukaemia.
@nl
prefLabel
Clinical importance of cytogenetics in acute myeloid leukaemia.
@ast
Clinical importance of cytogenetics in acute myeloid leukaemia.
@en
Clinical importance of cytogenetics in acute myeloid leukaemia.
@nl
P356
P1476
Clinical importance of cytogenetics in acute myeloid leukaemia.
@en
P2093
P356
10.1053/BEHA.2000.0114
P577
2001-03-01T00:00:00Z